LSD Archives • ShroomStocks.ca

Skip to the content Skip to the main menu

Investing is a trip

Featured Content
Mushrooms
Psychedelics
Psilocybin
Microdosing
Media

Top Posts & Pages

We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
Braxia Scientific (BRAX.C) files Q4 and year-end financials, including big losses
Filament Health (FH.NEO) Receives Regulatory Approval, Positioned to Lead Natural Psychedelic Research and Manufacturing
The City of Santa Cruz joins the shroom-boom
Nutritional High International (EAT.C) expands their psychoactive research to include peyote

Recent Posts

Red Light (TRIP.C) enters definitive agreement for Mera Life Sciences acquisition
Braxia Scientific (BRAX.C) files Q4 and year-end financials, including big losses
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Filament Health (FH.NEO) Receives Regulatory Approval, Positioned to Lead Natural Psychedelic Research and Manufacturing
MindMed (MND.Q) announces intravenous DMT Phase 1 study
Braxia Scientific (BRAX.C) CEO and Chief Medical Officer receive $918,000 grant to study ketamine assisted iCBT
Mind Cure (MCUR.C) launches second stage of ibogaine manufacturing
Psyched Wellness (PSYC.C) completes largest extraction of AME-1 to date and ships it to CRO in Asia
Cybin (CYBN.NE) receives conditional approval to list on the NYSE
Mydecine Innovations (MYCO.NE) files patent for MDMA-like compounds
Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia
Military veterans and RCMP officers to have ketamine treatment from Braxia Scientific (BRAX.C) fully covered by Medavie Blue Cross

About

Investing is a trip

Home
Posts

Top Posts & Pages

We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
Braxia Scientific (BRAX.C) files Q4 and year-end financials, including big losses
Filament Health (FH.NEO) Receives Regulatory Approval, Positioned to Lead Natural Psychedelic Research and Manufacturing
The City of Santa Cruz joins the shroom-boom
Nutritional High International (EAT.C) expands their psychoactive research to include peyote

Recent Posts

Red Light (TRIP.C) enters definitive agreement for Mera Life Sciences acquisition
Braxia Scientific (BRAX.C) files Q4 and year-end financials, including big losses
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Filament Health (FH.NEO) Receives Regulatory Approval, Positioned to Lead Natural Psychedelic Research and Manufacturing
MindMed (MND.Q) announces intravenous DMT Phase 1 study
Braxia Scientific (BRAX.C) CEO and Chief Medical Officer receive $918,000 grant to study ketamine assisted iCBT
Mind Cure (MCUR.C) launches second stage of ibogaine manufacturing
Psyched Wellness (PSYC.C) completes largest extraction of AME-1 to date and ships it to CRO in Asia
Cybin (CYBN.NE) receives conditional approval to list on the NYSE
Mydecine Innovations (MYCO.NE) files patent for MDMA-like compounds
Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia
Military veterans and RCMP officers to have ketamine treatment from Braxia Scientific (BRAX.C) fully covered by Medavie Blue Cross

About

Search for:

Category

LSD

Category

LSD

MindMed (MNMD.Q) add Dr. Peter Bergethon to Scientific Advisory Board

Post date
June 17, 2021
Posted by
Piers Eaton
Posted in Biotech, Dr. Bergethon, Eaton, Health Science, LSD, LSD research, Mind Medicine, MindMEd, mmed.ne, MNMD.Q, Psychedelics, research, SAB, Science, scientific advisory board, Scribes
Comments
0

Theme by Anders Norén